What they were paid
Spyre Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $47,500 | $0 | $248,675 | $0 | $296,175 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Spyre Therapeutics, Inc. DEF 14A filed April 10, 2026, accession 0001636282-26-000039, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Spyre Therapeutics pays directors a $40,000 cash retainer and $248,675 in equity.
Committees
FY2025 · as the proxy prints themCompensation
The rest of the Spyre Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Cameron Turtle | Director | $0 |
| Jeffrey Albers | Chair of the Board | $348,675 |
| Laurie Stelzer | Independent Director | $313,675 |
| Mark McKenna | Director | $288,675 |
| Michael Henderson | Independent Director | $298,675 |
| Peter Harwin | Independent Director | $293,675 |
| Sandra Milligan | Independent Director | $306,175 |
The full Spyre Therapeutics compensation record
free company briefThis page is one director within Spyre Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat